Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02459652
What this trial is testing

Neoadjuvant S-1 and Concurrent Radiotherapy for Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Japan Adjuvant Study Group of Pancreatic Cancer 57
Testing effectiveness (Phase 2)Looking for participantsNCT07131514
What this trial is testing

HRS-4642 in Combination With Gemcitabine and Albumin-bound Paclitaxel and Adebrelimab for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ruijin Hospital 30
Testing effectiveness (Phase 2)UnknownNCT01333332
What this trial is testing

Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer

Who this might be right for
Pancreatic Cancer
University of Virginia 35
Testing effectiveness (Phase 2)Looking for participantsNCT06782932
What this trial is testing

Comparing Neoadjuvant/Adjuvant GVAX vs a mKRASvax Given With Anti-PD-1 and Anti-CD137 for Surgically Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07415525
What this trial is testing

IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic CancerBorderline Resectable Pancreatic Adenocarcinoma
Zhejiang University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT05604560
What this trial is testing

A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer

Who this might be right for
Pancreatic Cancer
Lei Zheng 25
Not applicableStudy completedNCT02208024
What this trial is testing

Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body

Who this might be right for
Pancreatic Cancer
University of Cincinnati 18
Very early researchEnded earlyNCT03600623
What this trial is testing

Folfirinox or Gemcitabine-Nab Paclitaxel Followed by Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic CancerBorderline Pancreatic Inoperable CancerPancreatic Cancer
University of Alabama at Birmingham 25
Testing effectiveness (Phase 2)Looking for participantsNCT03977233
What this trial is testing

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Cancer of PancreasPancreatic Cancer, Adult+4 more
UNC Lineberger Comprehensive Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT00869258
What this trial is testing

Study for Inoperable Non-Metastatic Pancreatic CA (Stage IVA) With Neoadjuvant GTX, and Radiation With Gemzar

Who this might be right for
Pancreatic Cancer Stage IVA
Columbia University 32
Not applicableLooking for participantsNCT07647250
What this trial is testing

Pilot Study to Evaluate Targeted Physical Activity Among Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

Who this might be right for
Physiological Reactivity to CuesPhysical Exercise
University of Illinois at Chicago 25
Testing effectiveness (Phase 2)Study completedNCT01268384
What this trial is testing

Neoadjuvant FDR GX in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Asan Medical Center 43
Testing effectiveness (Phase 2)Study completedNCT02481635
What this trial is testing

Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University Health Network, Toronto 11
Not applicableNot Yet RecruitingNCT07592819
What this trial is testing

A Trial Using Transcriptomic Signatures to Personalize Neoadjuvant Chemotherapy (NAC) for Patients With Resectable Borderline Pancreatic Adenocarcinoma (PDAC)

Who this might be right for
Pancreas Adenocarcinoma (MSI-H)Pancreatic Cancer Resectable
Institut Paoli-Calmettes 367
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07469956
What this trial is testing

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Resectable
Sun Yat-sen University 30
Early research (Phase 1)UnknownNCT04425876
What this trial is testing

Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Jiangsu HengRui Medicine Co., Ltd. 74
Not applicableLooking for participantsNCT06595160
What this trial is testing

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic Ductal AdenocarcinomaStage I Pancreatic Cancer AJCC v8
Emory University 87
Not applicableUnknownNCT03202199
What this trial is testing

Neoadjuvant Chemotherapy Response Assessment by Combined PET-MRI in Borderline and Locally Advanced Pancreatic Adenocarcinoma.

Who this might be right for
Pancreatic Adenocarcinoma
Assistance Publique - Hôpitaux de Paris 125
Testing effectiveness (Phase 2)Study completedNCT01298011
What this trial is testing

Study of Gemcitabine and Abraxane to Treat Potentially Operable Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer
Pancreatic Cancer Research Team 25
Not applicableUnknownNCT04911647
What this trial is testing

A Prospective Randomized Multi-center Study for Efficacy of Metallic Biliary Stent Compared to Plastic Stent in Patients Receiving Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer

Who this might be right for
Resectable Pancreatic Cancer With Biliary Obstruction
Yonsei University 196
Next Page